183 related articles for article (PubMed ID: 33557789)
1. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
[TBL] [Abstract][Full Text] [Related]
2. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
[TBL] [Abstract][Full Text] [Related]
3. Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas.
Wu M; Wang X; Xie Y; Liu W; Zhang C; Ping L; Ying Z; Deng L; Zheng W; Lin N; Tu M; Song Y; Zhu J
Int J Med Sci; 2018; 15(9):867-874. PubMed ID: 30008598
[No Abstract] [Full Text] [Related]
4. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
5. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Simensen VC; Smeland KB; Kiserud CE; Dahl AA; Bersvendsen HS; Fluge Ø; Fagerli UM; Fosså A
Acta Oncol; 2019 Sep; 58(9):1315-1322. PubMed ID: 31286808
[No Abstract] [Full Text] [Related]
6. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.
Kondo E; Ikeda T; Izutsu K; Chihara D; Shimizu-Koresawa R; Fujii N; Sakai T; Kondo T; Kubo K; Kato Y; Akasaka T; Fukuda T; Ichinohe T; Atsuta Y; Suzumiya J; Suzuki R;
Biol Blood Marrow Transplant; 2019 May; 25(5):899-905. PubMed ID: 30664936
[TBL] [Abstract][Full Text] [Related]
7. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P
Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.
Ramamurthy A; Connolly EA; Mar J; Lewin J; Bhadri VA; Phillips MB; Winstanley M; Orme LM; Grimison P; Connor J; Lazarakis S; Hong AM; Omer N; Cayrol J
Cancer Treat Rev; 2024 Mar; 124():102694. PubMed ID: 38325070
[TBL] [Abstract][Full Text] [Related]
9. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gerrie AS; Power MM; Shepherd JD; Savage KJ; Sehn LH; Connors JM
Ann Oncol; 2014 Nov; 25(11):2218-2223. PubMed ID: 25149708
[TBL] [Abstract][Full Text] [Related]
11. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.
Lahoud OB; Sauter CS; Hamlin PA; Dahi PB
Curr Oncol Rep; 2015 Sep; 17(9):42. PubMed ID: 26201264
[TBL] [Abstract][Full Text] [Related]
12. High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.
Schorb E; Fox CP; Fritsch K; Isbell L; Neubauer A; Tzalavras A; Witherall R; Choquet S; Kuittinen O; De-Silva D; Cwynarski K; Houillier C; Hoang-Xuan K; Touitou V; Cassoux N; Marolleau JP; Tamburini J; Houot R; Delwail V; Illerhaus G; Soussain C; Kasenda B
Bone Marrow Transplant; 2017 Aug; 52(8):1113-1119. PubMed ID: 28436974
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
Bersvendsen HS; Haugnes HS; Fagerli UM; Fluge Ø; Holte H; Smeland KB; Wilsgaard T; Kiserud CE
Acta Oncol; 2019 May; 58(5):690-699. PubMed ID: 30696346
[No Abstract] [Full Text] [Related]
14. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.
Strehl J; Mey U; Glasmacher A; Djulbegovic B; Mayr C; Gorschlüter M; Ziske C; Schmidt-Wolf IG
Haematologica; 2003 Nov; 88(11):1304-15. PubMed ID: 14607760
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
[TBL] [Abstract][Full Text] [Related]
17. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
Smeland K; Holte H; Fagerli UM; Bersvendsen H; Hjermstad MJ; Loge JH; Murbrach K; Linnsund MD; Fluge O; Stenehjem JS; Lund MB; Kvaloy S; Kiserud CE
Haematologica; 2022 Nov; 107(11):2698-2707. PubMed ID: 35484681
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.
Kerhuel L; Amorim S; Azoulay E; Thiéblemont C; Canet E
Leuk Lymphoma; 2015; 56(11):3090-5. PubMed ID: 25813206
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
Correa DD; Braun E; Kryza-Lacombe M; Ho KW; Reiner AS; Panageas KS; Yahalom J; Sauter CS; Abrey LE; DeAngelis LM; Omuro A
J Neurooncol; 2019 Sep; 144(3):553-562. PubMed ID: 31377920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]